| Article | Added |
|---|
| Recipharm snags $114 million loan, says it's shopping | 05-24-12 |
| UPDATED: Marshals descend on Crescendo Therapeutics | 05-23-12 |
| Recipharm snags $114 million loan, says its shopping | 05-24-12 |
| Heart attack test alert from Alere | 05-24-12 |
| FDA takes aim at Spanish drugmaker | 05-24-12 |
| India encourages gelatin makers to bring it on | 05-24-12 |
| Marshals descend on Crescendo Therapeutics | 05-23-12 |
| FDA may impose more QA checks on heparin makers | 05-23-12 |
| Plant problems lead Alere to recall 800,000 heart meters | 05-24-12 |
| Counterfeit drugs threaten strides against malaria | 05-22-12 |
| Cipla partnership plans $50 million expansion in Uganda | 05-22-12 |
| FDA inspectors cite problems at Impax California plant | 05-21-12 |
| Chinese court favors J&J in distribution fight | 05-22-12 |
| Pfizer recalls 653,000 bottles of smelly Advil | 05-22-12 |
| Funding would allow FDA to target more foreign plants | 05-22-12 |
| UPDATED: Fewer recalls in Q1, but units pulled rocket with Novartis OTC issues | 05-17-12 |
| UPDATED: Hikma remediation to cost it generic sales | 05-17-12 |
| UPDATED: Hikma discloses FDA warning letter | 05-17-12 |
| Hikma discloses FDA warning letter | 05-17-12 |
| EU prepares tougher drug recall standards | 05-17-12 |
| Fewer recalls in Q1, but units pulled rocket with Novartis OTC issues | 05-17-12 |
| Bristol-Myers starts Orencia manufacturing at new plant | 05-17-12 |
| End is near for Watson distribution center | 05-16-12 |
| Pfizer making deep cuts at estrogen extraction plant | 05-16-12 |
| Review slams U.K. regulators over breast implant failures | 05-15-12 |
| Pakistan's ephedrine scandal takes on international intrigue | 05-14-12 |
| Merck KGaA says cuts will save $385 million | 05-15-12 |
| Another pain drug recall for Hospira | 05-15-12 |
| U.K. pharmacy group wants drug exports stopped | 05-15-12 |
| Contract manufacturer Vetter to open new high-tech warehouse | 05-15-12 |
| Ranbaxy to make drugs in Malaysia, Nigeria | 05-10-12 |
| FDA critical of Genentech's Avastin production | 05-10-12 |
| 12-year-old consent decree lifted from Abbott | 05-10-12 |
| Pfizer may announce $129M expansion in Belgium | 05-09-12 |
| Patheon exiting most manufacturing at U.K. plant | 05-09-12 |
| Pfizer may announce $129 million expansion in Belgium | 05-09-12 |
| Ranbaxy manufactures a colossal first quarter | 05-09-12 |
| UPDATED: Baxter bitten again by problems with Colleague infusion pumps | 05-08-12 |
| BASF erecting 50,000-ton-plus formic acid plant in Louisiana | 05-08-12 |
| Drug manufacturing problems bad for business but good for jobs | 05-08-12 |
| Baxter bitten again by problems with Colleague infusion pumps | 05-08-12 |
| Pfizer to grow manufacturing capacity in Indonesia | 05-08-12 |
| Sanofi closing plant in Missouri, 4 years later than expected | 05-08-12 |
| Warner Chilcott's Puerto Rico plant still beset by problems | 05-08-12 |
| BASF erecting 50,000-tonne formic acid plant in Louisiana | 05-08-12 |
| Hospira says temporary production glitch affecting propofol supplies | 05-03-12 |
| Merck expands packaging plant to take on more vaccines | 05-03-12 |
| With upgrades, India to reopen 3 vaccine plants | 05-03-12 |
| Genzyme's $150M plant upgrade starts to pay off | 05-03-12 |
| German Merck tracking drugs in Africa with texts | 05-03-12 |
| Workers killed in another API plant explosion | 05-01-12 |
| Updated: Claris says it satisfied FDA in plant inspection, awaits final word | 04-30-12 |
| Hospira earnings decline tied to ongoing remediation | 05-01-12 |
| FDA gives OK to Merck, Codexis for new green manufacturing process | 05-01-12 |
| Haemonetics, Pall ink $550M deal | 04-30-12 |
| BASF moves some production from Illinois to Germany | 05-01-12 |
| Claris claims it has passed FDA plant inspection | 04-30-12 |
| Amgen putting $200M into plant it bought from Pfizer | 04-26-12 |
| FDA, industry differ on level of track and trace needed in U.S. | 04-26-12 |
| Strides Arcolab picks up injectables plant | 04-26-12 |
| Sandoz transferring cGMP expertise to Africa's Cinpharm | 04-26-12 |
| Fixing OTC production problems is a top priority for new J&J CEO | 04-26-12 |
| Amgen VP warns FDA about quashing manufacturing innovation of biosimilars | 04-25-12 |
| Novartis remediation drags on longer than expected | 04-25-12 |
| Novartis invests $550 million in flexible, modular processes at new plant | 04-23-12 |
| UPDATED: Alli sale still held hostage by Roche GMP issues | 04-23-12 |
| Life Technologies expands manufacturing in Scotland | 04-24-12 |
| Alli sale still held hostage by Roche GMP issues | 04-23-12 |
| China seizes 77 million tainted drug capsules in crackdown | 04-24-12 |
| Pfizer, J&J, Abbott facing shortages of crucial ingredients in Pakistan | 04-24-12 |
| New $550M Novartis plant in Stein part of larger expansion | 04-23-12 |
| Merck KGaA manufacturing dodges worst of reductions | 04-24-12 |
| UPDATED: U.S. Marshals seize ultrasound gel containing dangerous levels of bacteria | 04-18-12 |
| Incentives entice Mylan to expand in Ireland | 04-19-12 |
| GAO hammers FDA for not updating IT system, using faulty system to track foreign drugmakers | 04-19-12 |
| J&J plant overhaul turning into 4-year project | 04-18-12 |
| CSL recalling product tainted with ethylene glycol | 04-19-12 |
| Baxter to erect $1B plasma plant | 04-19-12 |
| U.S. Marshals seize ultrasound gel containing dangerous levels of bacteria | 04-18-12 |
| U.S.. Marshals seize ultrasound gel containing dangerous levels of bacteria | 04-18-12 |
| Manufacturing issues continue to undermine J&J earnings | 04-17-12 |
| Innovative construction project boosts Merck's Zostavax manufacturing | 04-17-12 |
| Penn Pharma expanding manufacturing in South Wales, U.K. | 04-16-12 |
| Innovative construction project boosts Merck's Zosavax manufacturing | 04-17-12 |
| South Africa creates list of drugs it will buy only if they are made there | 04-17-12 |
| Samsung says its manufacturing 'DNA' will provide big biosimilar savings | 04-16-12 |
| China investigates 43 drug manufacturers tied to adulterated drug capsules | 04-16-12 |
| Surya Pharmaceuticals closes 2 Indian API plants | 04-12-12 |
| PET drug producers under gun to meet FDA rule | 04-12-12 |
| 3 big animal drugmakers volunteer to change labels | 04-12-12 |
| Malaysian genericsmaker in talks to buy manufacturing facility in Indonesia | 04-11-12 |
| Some supply issues expected from Teva plant in Croatia | 04-12-12 |
| Hospira taps drug industry veteran to oversee operations | 04-12-12 |
| New plant pushes Ranbaxy Lipitor production to global lead | 04-10-12 |
| J&J considers manufacturing workaround for Doxil | 04-10-12 |
| FDA disbars 4 quality control execs from defunct Able Laboratories | 04-10-12 |
| FDA builds program for outsourcing foreign plant inspections | 04-09-12 |
| India considers track and trace system to combat counterfeiters | 04-09-12 |
| McCoy, who has been dealing with J&J's OTC issues, leaves for Avon | 04-10-12 |
| Oridion picked up by Covidien, still under partial FDA ban | 04-05-12 |
| FDA bans all products from Pax-All Manufacturing plant | 04-05-12 |
| Abbott gets more incentives for its new Ensure plant | 04-05-12 |
| Here are some tips on cargo theft that might save you $75M | 04-04-12 |
| Company tied to fake Avastin shipped other adulterated drugs | 04-04-12 |
| FDA cites 32 contamination complaints at biologics maker | 04-05-12 |
| With new plant, Ranbaxy back in force in North America | 04-05-12 |
| Novasep drawing on ?40 million to fund international expansion | 04-03-12 |
| FDA says NuSil must get at root of contamination | 04-03-12 |
| FDA creates new standard for cargo theft | 04-02-12 |
| Ranbaxy shipping generic Lipitor from new Indian plant | 04-02-12 |
| Check out the new and improved FiercePharmaManufacturing website | 04-03-12 |
| Gerresheimer completes BRIC positioning with India acquisition | 04-02-12 |
| Sandoz Canada president explains shortages to House of Commons | 03-29-12 |
| Halo agrees to buy Teva's Montreal facility | 03-29-12 |
| Novartis plant disruptions affect pet treatments | 03-28-12 |
| CMC, third-party manufacturing issues delay Map drug launch | 03-29-12 |
| California implant makers get FDA warnings | 03-29-12 |
| FDA slams unlicensed firm injecting 'stem cells' for cosmetic treatments | 03-27-12 |
| Pharma cargo theft in Canada violent and getting worse | 03-27-12 |
| Pfizer returns Xanax to UAE | 03-27-12 |
| Positron goes nuclear in Indiana | 03-26-12 |
| Stop using DBP and DEHP, FDA says | 03-27-12 |
| India's Shasun to invest about $50M in manufacturing capacity | 03-27-12 |
| State lab in Argentina to make, distribute sildenafil | 03-26-12 |
| Congress probes whether small wholesalers are gouging drug prices | 03-22-12 |
| Nobilus Poland plant gets import ban after FDA warning | 03-22-12 |
| Distribution, supply chain key to Eli Lilly's China expansion | 03-22-12 |
| Explosion, fire at Teva's Pliva plant turns deadly | 03-22-12 |
| GSK to invest more than £500 million in new manufacturing in U.K. | 03-22-12 |
| Sandoz finds outside suppliers for drugs in shortage | 03-21-12 |
| Fire disrupts production at Teva plant in Croatia | 03-20-12 |
| Warehouse strike creates drug shortages in Australia | 03-20-12 |
| Pfizer, Lilly and Sanofi help authorities break up counterfeiters | 03-20-12 |
| Sandoz's role in Canadian drug shortages adds to calls for regulation | 03-20-12 |
| FDA says APP ignored consumer complaints for 18 months | 03-20-12 |
| Apotex says FDA import ban, delays 'decimated' its business | 03-19-12 |
| Pfizer CEO: More than 50 fakes of our drugs discovered last year | 03-15-12 |
| Omega gets German plant as part of OTC deal with GSK | 03-15-12 |
| Pfizer's new U.K. cold storage facility has hot new vaccines line | 03-15-12 |
| J&J's Weldon to get $143M in retirement | 03-15-12 |
| Sanofi cuts continue with closing of manufacturing plant in U.K. | 03-15-12 |
| Industry stymies effort to make it fund drug disposal program | 03-14-12 |
| U.K. drug regulator asks industry to name the rules it wants to go | 03-13-12 |
| FDA says 5 years of Warner Chilcott's Ovcon BC pills suspect | 03-13-12 |
| WHO joins agencies in beefing up inspections of API facilities | 03-13-12 |
| Fire at Sandoz plant complicates drug shortages | 03-13-12 |
| Litigation: Sanofi, Genzyme 'negligently allowed a virus contamination in the manufacturing facility' | 03-12-12 |
| Loss of manufacturing contract takes toll on Patheon | 03-12-12 |
| FDA cites company making 'baby switching' protection kit | 03-08-12 |
| AMRI names quality control director for troubled plant, following lead of J&J, Novartis, others | 03-08-12 |
| Almac builds on U.S. expansion with $10M pharmaceutical packaging plant | 03-08-12 |
| FDA threatens fines, regulatory action over Synthes' GMP problems | 03-08-12 |
| Fake of Roche's Avastin shipped from Canadian supplier | 03-08-12 |
| GE Healthcare moves further into biopharmaceutical field, buys Xcellerex | 03-08-12 |
| FDA cites Gulf Pharmaceutical for predating documentation | 03-06-12 |
| GlaxoSmithKline, Daiichi Sankyo join forces to sell vaccines in Japan | 03-06-12 |
| Boehringer Ingelheim spends ?17M on expansion in Germany, Vienna | 03-06-12 |
| AmerisourceBergen buys another pharmaceutical services company | 03-06-12 |
| India's Emcure to manufacture Roche's Herceptin, MabThera | 03-06-12 |
| Boehringer Ingelheim spends ?17 million on expansion in Germany, Vienna | 03-06-12 |
| Novartis names new leader for its troubled OTC operations | 03-06-12 |
| Industry faces having to fund drug-disposal program | 03-01-12 |
| IT issues at Biochem lab raise data integrity concerns | 03-01-12 |
| FDA puts burning questions to Fukuda Denshi about device | 02-29-12 |
| Abbott banks on boomers with $270M nutrition facility | 03-01-12 |
| Ranbaxy CEO to ride out transformation under DOJ oversight | 03-01-12 |
| Industry faces having to fund of drug disposal program | 03-01-12 |
| FDA seeks 3 years of heparin test results from APP Pharmaceuticals | 02-29-12 |
| GSK pulls blood pressure pills made at Novartis plant | 02-28-12 |
| Ranbaxy's manufacturing mess results in $606M loss | 02-23-12 |
| FDA device regulator calls for more authority | 02-28-12 |
| Fake Avastin contains salt, starch | 02-28-12 |
| Cargo theft in Brazil violent and growing | 02-27-12 |
| Birth control redux: Glenmark Generics pulling mixed-up pills | 02-27-12 |
| Lilly outlines $442M Ireland plans | 02-27-12 |
| Pharmacists may seek arbitration to get recall costs from GSK | 02-23-12 |
| Pharma says EU GDP proposals expensive, supply-chain nightmare | 02-23-12 |
| Shire's $200 million LEED-certified plant gets EMA nod | 02-23-12 |
| FDA triples list of banned Chinese heparin ingredient makers | 02-23-12 |
| Ranbaxy's manufacturing mess results in $606 million loss | 02-23-12 |
| J&J Recall: Manufacturing issues believed behind CEO departure | 02-22-12 |
| Teva expected to pay big bucks for decision to use oversized vials | 02-23-12 |
| Shire's $200 million Leed certified plant gets EMA nod | 02-23-12 |
| Leader of Pakistan drugmakers resigns in frustration | 02-21-12 |
| UPDATED: Novartis suspends production at another plant | 02-21-12 |
| VP of China shows up for signing of Pfizer, Hisun deal | 02-21-12 |
| Hospira on track with expansions in India | 02-21-12 |
| Novartis halts production at another plant | 02-21-12 |
| UPDATED: Teva halts production of drug in U.K. | 02-21-12 |
| Leader of Pakistan drug makers resigns in frustration | 02-21-12 |
| Teva halts production of drug in U.K. | 02-21-12 |
| Avastin alert likely to revive discussion of pharma-financed tracking system | 02-18-12 |
| UPDATED: FDA inspects three Merck KGaA plants along EU supply chain | 02-16-12 |
| West-Ward hit with FDA warning letter over manufacturing, testing problems | 02-16-12 |
| UPDATED: FDA inspects three Merck plants along EU supply chain | 02-16-12 |
| Integra collagen plant fights mold | 02-14-12 |
| West-Ward hit with warning letter over manufacturing, testing problems | 02-16-12 |
| U.S. market size, shortages lead to more counterfeits | 02-16-12 |
| FDA inspects three Merck plants along EU supply chain | 02-16-12 |
| Hospira sees dim light at end of plant troubles | 02-15-12 |
| FDA sees advances in manufacturing as key to biosimilar abbreviated path | 02-13-12 |
| Hospira beefs up quality management team | 02-13-12 |
| Federal charges filed against Dallas compounding pharmacy | 02-13-12 |
| FDA asks heparin makers to test APIs for contaminants, including BSE | 02-13-12 |
| South Africa, Lonza partner on $210 million API facility | 02-13-12 |
| Ben Venue can't say when crucial cancer drug will be available | 02-13-12 |
| Dramatic decrease in pharma cargo thefts seen in 2011 | 02-10-12 |
| Fallout from Ben Venue manufacturing shutdown could turn tragic | 02-13-12 |
| Projects in India, Belgium expand OmniChem's API capacities | 02-06-12 |
| Another generic settlement: Janssen, Watson agree on birth control pill | 02-08-12 |
| ViroPharma responding quickly to FDA delay of Cinryze manufacturing expansion | 02-08-12 |
| Decision on new GSK plant location to come soon | 02-09-12 |
| Ernst & Young nailed for $2 million for accounting on Medicis | 02-09-12 |
| Pakistan Supreme Court interjects itself in drug death scandal | 02-09-12 |
| Being more like Coca-Cola takes days out of GSK's pharma supply chain | 02-09-12 |
| Dishman set to bail on API manufacturing in once-promising China | 02-05-12 |
| AstraZeneca faces resistance to job cuts on home turf | 02-07-12 |
| Providing insight into pharmaceutical manufacturing requires conversation | 02-01-12 |
| Smith & Nephew eliminating 800 jobs, restructuring already felt in Memphis | 02-05-12 |
| FDA report shows deep problems at closed Novartis Consumer Health plant | 02-07-12 |
| Merck's manufacturing information not trade secrets, court rules | 02-06-12 |
| Executive suite not spared in J&J reorg tied to quality concerns | 02-02-12 |
| Medical devicemakers double down on FDA | 02-01-12 |
| Pfizer suspects 30 packs of contraceptives mispackaged; pulls 1 million just in case | 02-02-12 |
| Roche plant spared from sale runs into GMP issues | 02-02-12 |
| Amylin's OH plant prepped for Bydureon's U.S. debut | 02-01-12 |
| Pakistan drug manufacturers make plea for oversight | 02-01-12 |
| Novartis says Nebraska plant to reopen midyear | 01-31-12 |
| Gutted J&J consumer healthcare plant another year from reopening | 01-30-12 |
| Medicines Company, APP settlement includes manufacturing agreement | 01-30-12 |
| Teva's Cephalon recalls leukemia drug over fragments in vial | 01-31-12 |
| Company whistleblower program part of Ranbaxy consent decree | 01-30-12 |
| Pfizer workers at manufacturing hub sue over whiplashed retirement plans | 01-31-12 |
| Lonza board boots CEO Borgas | 01-26-12 |
| Ranbaxy, FDA enter consent decree over GMP, data breaches | 01-26-12 |
| Warnings analysis spotlights analytics weakness | 01-26-12 |
| Merck 'program of projects' earns facility award | 01-25-12 |
| Owner arrested in Pakistani drug deaths cites Big Pharma conspiracy | 01-26-12 |
| Abbott includes manufacturing in 700 job cuts | 01-25-12 |
| Genzyme plant approval marks GMP comeback | 01-24-12 |
| Pakistan suspects heart drug contamination in patient deaths, seals plant | 01-23-12 |
| GSK's CEO Witty wants U.K. focus on manufacturing | 01-24-12 |
| Law firm brings logistics savvy to Miami | 01-21-12 |
| Pfizer revels in massive Prevnar vax job | 01-23-12 |
| Balance adaptability, planning in supply chain, Tompkins advises | 01-23-12 |
| Roche workers protest use of contractors | 01-24-12 |
| Toray takes stake in Mitsui bio-CMO | 01-19-12 |
| Genzyme revives Fabrazyme with EMA plant OK | 01-18-12 |
| Lean earns Lundbeck big prize, cost cuts | 01-18-12 |
| Bioprocess budget hikes a sign of efficiency quest | 01-19-12 |
| Novartis, Lundbeck score wins for manufacturing in the West | 01-18-12 |
| Congresswoman: Novartis troubles call for more FDA oversight | 01-19-12 |
| Takeda consumption of Nycomed to cost 2,800 jobs | 01-18-12 |
| UPDATED: USP has credibility as pedigree driver | 01-13-12 |
| B.S., M.S. manufacturing jobs grow with R&D cutbacks | 01-16-12 |
| Abbott dodges excise tax at Indian plant | 01-16-12 |
| Roche pilots direct shipments to Europe | 01-17-12 |
| FDA: Novartis plant shows patterns of problems | 01-16-12 |
| USP has credibility as pedigree driver | 01-13-12 |
| Daiichi sends Japanese execs to new Ranbaxy plant in India | 01-17-12 |
| Stability skimping a frequent component in FDA warnings | 01-12-12 |
| Interview: M+W on lean plants and carmakers | 01-11-12 |
| It's 'T' time for contract manufacturers | 01-11-12 |
| FDA seeks electronic reporting of drug stability tests | 01-12-12 |
| Global shippers unite against EU tariff | 01-12-12 |
| Pfizer, KV listed in 2011's 'spectacular' exec departures | 01-12-12 |
| Genzyme's new plant to boost Fabrazyme supply | 01-10-12 |
| Novartis recall hints at regulatory snowball | 01-10-12 |
| ADHD community seeks DEA action in med shortages | 01-10-12 |
| Parents allege J&J's excess-API Tylenol killed son | 01-09-12 |
| USP suits up for pedigree challenge | 01-09-12 |
| Xoma cuts manufacturing to feed R&D | 01-09-12 |
| Personalized med labeling may be cure for over-warning syndrome | 01-04-12 |
| Novartis adds OTC drug plant to GMP fix list | 01-05-12 |
| Report: Big Pharma finds Indian collaborations costly | 01-04-12 |
| Expired-drug take vs. toss debate gets new vetting | 01-04-12 |
| AZ starts work on record-setting plant in China | 01-04-12 |
| Pharma fires, pollution targeted in India | 01-04-12 |
| Ben Venue lengthens remediation timeline | 01-02-12 |
| Flu vax tool aids strain identification, timing | 01-03-12 |
| Infant pain reliever dosing 'fix' shows label limitations | 01-02-12 |
| Hospira enters angry-investor phase of remediation | 01-03-12 |
| H&P/Triad, under decree, will recondition seized wipes | 01-02-12 |
| Rockline quietly recalls contaminated wipes | 12-30-11 |
| Patheon ops 'transformation' aligns with Q4 losses | 12-22-11 |
| FDA cites Akzo for contamination, leaky equipment | 12-22-11 |
| Counterfeiter with Chinese connections is busted | 12-21-11 |
| Daiichi grimaces at Ranbaxy, FDA consent decree | 12-21-11 |
| Trout forges ahead on Novartis-MIT continuous processing effort | 12-21-11 |
| Troubles top 2011 topics; time for holiday break | 12-21-11 |
| Generics makers step up for shortages response | 12-20-11 |
| FDA gets interim club to fight drug shortages | 12-20-11 |
| Sanofi's Shan5 vaccine to restart in 2013 | 12-20-11 |
| Celltrion boasts worldwide tech lead in biosimilars | 12-20-11 |
| Eli Lilly bulks up in Ireland | 12-20-11 |
| Catalent rethinks stainless for new bio plant | 12-19-11 |
| EU reg to halt export of death penalty drug | 12-15-11 |
| Forecast: Pharma wants CMO consulting, regulatory support | 12-15-11 |
| Novartis, HHS unveil pandemic-ready vax plant | 12-15-11 |
| Study finds substandard drugs cheaper than fakes | 12-14-11 |
| Watch for pharma/carmaker collaboration pitfalls | 12-14-11 |
| J&J releases Doxil batch; Ben Venue troubles detailed in FDA report | 12-14-11 |
| Packaging veteran urges including patient in drug pedigree chain | 12-12-11 |
| Endo unveils crush-resistant opioid | 12-13-11 |
| Pharma companies come to aid of compliance-challenged North Pole CEO | 12-13-11 |
| Actavis, Mylan continue defense in Digitek API suits | 12-12-11 |
| KV reports doubt about viability under decree | 12-12-11 |
| Packing veteran urges including patient in drug pedigree chain | 12-12-11 |
| Europe issues 2nd recall of drugs made by Ben Venue | 12-12-11 |
| Pfizer briefs NJ public on Superfund site cleanup | 12-07-11 |
| Samsung, Biogen Idec team on biosimilars | 12-07-11 |
| CMO capacity expansions mirror market | 12-07-11 |
| Analysts ponder takeover of ailing Hospira | 12-08-11 |
| Catalent to go disposable in new plant | 12-08-11 |
| FDA notes lack of Novartis exec response in 3-site warning | 12-07-11 |
| UPS, Lufthansa seize Asian logistics opportunity | 12-06-11 |
| Issue separates bio, small molecule CMOs | 12-05-11 |
| Online vaccines available from suspect sources | 12-05-11 |
| Pfizer presence unmistakable in 1940s Brooklyn | 12-06-11 |
| Theravance MRSA drug a victim of Ben Venue shutdown | 12-05-11 |
| MA anticipates bioprocess job increase | 12-06-11 |
| GSK a step closer to becoming energy provider | 12-01-11 |
| Analyst: Hospira manufacturing woes possibly systemic | 11-30-11 |
| Ranbaxy drama shows manufacturing impact on pharma business | 12-01-11 |
| Contamination concern rises about CMOs | 11-30-11 |
| Police net $8 million in counterfeit drugs | 12-01-11 |
| Fujifilm presses biosimilars ambition | 12-01-11 |
| GAO, FDA identify tactics to fight economic adulteration | 11-29-11 |
| Mylan warned by FDA on testing failures | 11-28-11 |
| Hospira to spend $375M in manufacturing upgrades | 11-28-11 |
| Europe takes precautions with Ben Venue drugs | 11-28-11 |
| McKesson, J&J eye GHX platform for e-pedigree | 11-29-11 |
| Ranbaxy, FDA near $400M deal on longstanding violations | 11-28-11 |
| J&J yields to activists on baby-product chemicals | 11-21-11 |
| Thanks for a miracle in Congress | 11-21-11 |
| Ben Venue shutdown strains J&J drug supply | 11-21-11 |
| Bill cites fakes dangers, ups penalties | 11-21-11 |
| Counterculture drugmaker spoofs Big Pharma | 11-22-11 |
| Compounder questions KV's Makena purity claim | 11-22-11 |
| J&J responds to activists on baby-product chemicals | 11-21-11 |
| UPDATED: FDA visits Indian plant after meningitis outbreak | 11-14-11 |
| Second take on short-supply drug markups exonerates distributors | 11-17-11 |
| UCB to set up major bioprocessing plant in Switzerland | 11-16-11 |
| Aesica CEO Hardy makes CDMO business fly | 11-17-11 |
| Strikers want Dr. Reddy promise of regular work | 11-17-11 |
| Merck leans on suppliers, partners to expand reach | 11-16-11 |
| Novartis workers strike to forestall plant closure | 11-17-11 |
| Pfizer transforms manufacturing for 'dynamic market' | 11-11-11 |
| FDA visits Indian plant after meningitis outbreak | 11-14-11 |
| Five die in pharma plant fire | 11-14-11 |
| Booz offers 5 steps to reinvent supply chain | 11-15-11 |
| AMA counts to 10 before voting drug shortages position | 11-15-11 |
| IMS advises risk-based warning system for drug shortages | 11-14-11 |
| KV crows over Makena purity as FDA checks claim | 11-10-11 |
| OxyContin abuse overshadows formulation fix | 11-10-11 |
| Manufacturing embraces IT as some drugmakers minimize R&D focus | 11-10-11 |
| Chinese pharma exec gets suspended death sentence | 11-09-11 |
| Genentech, INIS demonstrate art of FDA response | 11-09-11 |
| International Isotopes gets FDA warning | 11-09-11 |
| Dr. Reddy's strike brings police, tear gas | 11-04-11 |
| MedImmune cell-culture plant named facility of the year | 11-08-11 |
| Dr. Reddy's strike brings police, teargas | 11-04-11 |
| Disposables push sterilization onus to suppliers | 11-04-11 |
| Plant check reveals Genentech report flaw repeat | 11-08-11 |
| Pharma recalls up 54% in Q3 | 11-08-11 |
| Accucaps maker describes need for gel-cap manufacturing finesse | 11-08-11 |
| UPDATED:Drugmakers respond to shortages order, HHS report | 11-03-11 |
| Drugmakers respond to shortages order, HHS report | 11-03-11 |
| Baxter Healthcare - Fierce's 2011 warning letters report | 11-03-11 |
| Klinge Chemicals - Fierce's 2011 warning letters report | 11-03-11 |
| Hawkeye-Jensen - Fierce's 2011 warning letters report | 11-03-11 |
| Scientific Protein Laboratories - Fierce's 2011 warning letters report | 11-03-11 |
| Sichuan Pharmaceutical - Fierce's 2011 warning letters report | 11-03-11 |
| Dr. Reddy's Mexico - Fierce's 2011 warning letters report | 11-03-11 |
| L. Perrigo - Fierce's 2011 warning letters report | 11-03-11 |
| Daiichi Sankyo/Luitpold Pharmaceuticals/American Regent - Fierce's 2011 warning letters report | 11-03-11 |
| Jelfa Pharmaceutical - Fierce's 2011 warning letters report | 11-03-11 |
| Yag-Mag Labs - Fierce's 2011 warning letters report | 11-03-11 |
| Golden State Medical Supply - Fierce's 2011 warning letters report | 11-03-11 |
| Fierce's 2011 warning letters report | 11-03-11 |
| Ningbo Smart Pharmaceutical - Fierce's 2011 warning letters report | 11-03-11 |
| FDA details its actions on shortages | 11-02-11 |
| HHS details manufacturing role in drug shortages | 11-02-11 |
| China ready to take on the world | 11-02-11 |
| GSK, Pfizer set HIV drug manufacturing in Russia | 11-02-11 |
| GSK, Alnylam team to speed vaccine production | 11-01-11 |
| Obama takes aim at drug shortages | 11-01-11 |
| Closures a sign of Novartis minimizing production in Switzerland | 11-01-11 |
| KV Pharma, ex-CEO battle over recall responsibility | 10-31-11 |
| Ranking: Baxter, J&J lead green pharma companies | 11-01-11 |
| Researchers tout big increase in heparin yield | 10-31-11 |
| UPDATED: Sanofi licenses hard-to-make allergy drug to Acton | 10-26-11 |
| Cardinal and McKesson positive, upbeat on financials | 10-27-11 |
| Jobhunters: Demand rising for bioprocessing expertise | 10-27-11 |
| Baxter issues precautionary recall of flu vaccine | 10-26-11 |
| China to ramp up epidemic vax system | 10-27-11 |
| Sanofi licenses hard-to-make asthma drug to Acton | 10-26-11 |
| UPDATED: Astellas gets EMA OK for precautionary Advagraf recall* | 10-24-11 |
| Novartis to cut 2,000 jobs in ops restructuring | 10-25-11 |
| Astellas gets EMA OK for precautionary Advagraf recall* | 10-24-11 |
| Actavis shipment of opioids stolen from truck stop | 10-24-11 |
| Astellas recall triggered by excess API in capsules | 10-24-11 |
| 'Little things' blossomed into big QA trouble at J&J/McNeil | 10-25-11 |
| APP, Hospira resolve shortage of cytarabine | 10-24-11 |
| Sanofi manufacturing glitch yields insulin pen shortage | 10-24-11 |
| Woodcock: More predictable manufacturing may ease regulations | 10-24-11 |
| Rogue online pharmacies try Twitter marketing | 10-20-11 |
| Prevention efforts yield 33% drop in cargo theft | 10-20-11 |
| Ben Venue inspection yields 48 GMP violations | 10-19-11 |
| APP taps parent Fresenius' facilities to boost propofol supply | 10-19-11 |
| Hospira plant remediation stings company financials | 10-19-11 |
| GSK warned over lack of contamination control | 10-19-11 |
| Ranbaxy recalls three drugs for lack of safety warnings | 10-17-11 |
| Purdue, Endo answer calls to deal with painkiller abuse | 10-17-11 |
| Quality meltdown still affects J&J financials, though Q3 sales are up | 10-18-11 |
| FDA: Drug shortages expected to increase | 10-17-11 |
| Senate bill would ease FDA conflict-of-interest rule | 10-14-11 |
| GSK site pulls out all stops in plant-investment competition | 10-14-11 |
| Teva walloped $163M in hepC ruling, doc 'unfit' for trial | 10-12-11 |
| Ex-Genzyme ops chief joins board at bio start-up | 10-12-11 |
| Survey: Disposables adoption stymied by lack of standards | 10-11-11 |
| China assesses illegal drug activities | 10-12-11 |
| Genzyme's Ireland site expanded | 10-12-11 |
| Pain patch maker warned by FDA over validation reporting | 10-12-11 |
| Sen. Schumer asks FTC to probe gray market mark-ups in drug shortages | 10-10-11 |
| Kimberly-Clark program gives new life to cleanroom garb | 10-10-11 |
| Sanofi's Viehbacher sees green lights ahead for Shantha | 10-10-11 |
| AZ ups emerging markets bet with $200M plant in China | 10-10-11 |
| Teva, partners fined $20M in second propofol/Hep-C case | 10-10-11 |
| Counterfeits quantified | 10-10-11 |
| AAIPharma Services - Top 10 Standout CMOs | 10-06-11 |
| Cedarburg Pharmaceuticals - Top 10 Standout CMOs | 10-06-11 |
| Pfizer CentreSource - Top 10 Standout CMOs | 10-06-11 |
| Recipharm - Top 10 Standout CMOs | 10-06-11 |
| Boehringer Ingelheim - Top 10 Standout CMOs | 10-06-11 |
| Hospira One 2 One - Top 10 Standout CMOs | 10-06-11 |
| Xcelience - Top 10 Standout CMOs | 10-06-11 |
| Ben Venue - Top 10 Standout CMOs | 10-06-11 |
| UPM Pharmaceuticals - Top 10 Standout CMOs | 10-06-11 |
| Top 10 Standout CMOs | 10-06-11 |
| Therapure Biopharma - Top 10 Standout CMOs | 10-06-11 |
| Baxter faces land contamination suit in PR | 10-05-11 |
| Rep. Cummings finds drug shortage gray market prospering | 10-05-11 |
| MIT's Hockfield reports worrisome lack of interest in manufacturing | 10-05-11 |
| Hospital perspective of shortages casts pharma earnings in bad light | 10-06-11 |
| Saudi Arabia continues to beckon Big Pharma | 10-05-11 |
| FDA grants to boost manufacturing, regulatory science | 10-06-11 |
| Lonza readies as pharma sector boosts Singapore production | 10-03-11 |
| DHL, pharma group assess India's hobbled logistics | 10-03-11 |
| Boehringer to launch biosimilars unit | 10-03-11 |
| Novo to enhance insulin in manufacturing/marketing strategy | 10-03-11 |
| FDA: Product quality issues fuel rise in drug shortages | 10-03-11 |
| Hill Dermaceuticals enters consent decree with FDA | 10-03-11 |
| Chinese API maker gets stern FDA warning over cross-contamination | 09-28-11 |
| GSK planning off-grid move for savings | 09-28-11 |
| Lean manufacturing lessons from Human Genome Sciences | 09-28-11 |
| Google AdWords ban keeps drug savings from U.S. poor | 09-28-11 |
| Congress gets started on drug-takeback program | 09-28-11 |
| The downside of downsizing: playing it safe | 09-29-11 |
| Ex-U.S. contracting may be Tylenol's path of least resistance | 09-23-11 |
| Taiwan take-down nets fakes-makers, retailers | 09-26-11 |
| Bayer, union at odds over outsourcing promised jobs | 09-26-11 |
| Drug in regulatory limbo a headache for Shire, FDA | 09-27-11 |
| Merck, MedImmune deal space | 09-26-11 |
| Barcode is India's choice of track/trace weapon | 09-27-11 |
| Chinese drugmakers turn up heat on India | 09-21-11 |
| Pfizer's Grange Castle to be QC mecca | 09-21-11 |
| Rx-360 launch reinforces benefits of shared audits | 09-21-11 |
| West-Ward sees shortages as 'major opportunity' | 09-21-11 |
| DHL jockeys for pharma logistics biz in China | 09-21-11 |
| With help from state, GSK adds jobs in Montana | 09-21-11 |
| Genzyme's shortage opens door to rival Protalix | 09-19-11 |
| Flying high on Elan deal, Alkermes gets to work on Big Pharma project | 09-19-11 |
| Offshore generics makers eye biosimilars | 09-20-11 |
| Pharma discharge study reveals big impact on fish | 09-19-11 |
| Sun gets NJ plant back on GMP track, still working on Detroit facility | 09-19-11 |
| SCM flexes formulation muscle for Mitovie | 09-19-11 |
| Remediation effort keeps Genzyme in step with Protalix | 09-19-11 |
| Sun gets NJ plant back on GMP track, Detroit still in process | 09-19-11 |
| Competition forcing marriage of iPads, ops data for execs | 09-14-11 |
| Competition forcing shotgun marriage of iPads, ops data for execs | 09-14-11 |
| Teva gets close-out letter over Jerusalem plant | 09-14-11 |
| Medicago facility cranks up for VLP vax production | 09-13-11 |
| Seattle the exception in hosting medical marijuana dispensaries | 09-14-11 |
| Catalent expansions show close pharma-biz tracking | 09-14-11 |
| Daiichi riding GMP rollercoaster with FDA | 09-14-11 |
| iPad can be lean enabler in hands of execs | 09-12-11 |
| Patheon reveals strategy amid poor financials | 09-12-11 |
| Survey: Pharma hiring on the rise | 09-13-11 |
| Roche tops DJ healthcare sustainability index | 09-12-11 |
| German trial a step toward upcoming track/trace mandate | 09-12-11 |
| Dendreon deals body blow to manufacturing ops | 09-09-11 |
| Labor follows lead of Genzyme, others in green tie-up | 09-08-11 |
| Brioschi antacid on a comeback, bringing manufacturing jobs to NY | 09-08-11 |
| Pfizer pushes iPads toward factory floor | 09-08-11 |
| Pharma's cold need is opportunity in all parts of supply chain | 09-07-11 |
| Price overlap blurs quality between generic, substandard drugs | 09-07-11 |
| Study finds quality risk gap between U.S., Puerto Rico plants | 09-07-11 |
| Vax maker CSL on road to GMP compliance | 09-05-11 |
| Pharma deal-making minimizes manufacturing | 09-05-11 |
